Education
About Us
Working with TipRanks
Follow Us
Wai Yuen Tong Medicine Holdings Limited (HK:0897)
:0897
Total Valuation
Wai Yuen Tong Medicine Holdings Limited has a market cap or net worth of HK$461.29M. The enterprise value is HK$708.53M.
Market CapHK$461.29M
Enterprise ValueHK$708.53M
Share Statistics
Wai Yuen Tong Medicine Holdings Limited has 1,125,102,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,125,102,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Wai Yuen Tong Medicine Holdings Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -3.33%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-3.33%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee912.24K
Profits Per Employee4.99K
Employee Count817
Asset Turnover0.43
Inventory Turnover1.55
Valuation Ratios
The current PE Ratio of Wai Yuen Tong Medicine Holdings Limited is ―. Wai Yuen Tong Medicine Holdings Limited’s PEG ratio is -0.38.
PE Ratio―
PS Ratio0.54
PB Ratio0.34
Price to Fair Value0.34
Price to FCF5.39
Price to Operating Cash Flow13.27
PEG Ratio-0.38
Income Statement
In the last 12 months, Wai Yuen Tong Medicine Holdings Limited had revenue of 745.30M and earned 7.10M in profits. Earnings per share was 0.01.
Revenue745.30M
Gross Profit376.45M
Operating Income-31.70M
Pretax Income4.08M
Net Income7.10M
EBITDA122.72M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 115.20M and capital expenditures -27.16M, giving a free cash flow of 88.04M billion.
Operating Cash Flow115.20M
Free Cash Flow88.04M
Free Cash Flow per Share0.08
Dividends & Yields
Wai Yuen Tong Medicine Holdings Limited pays an annual dividend of HK$0.03, resulting in a dividend yield of 6.98%
Dividend Per ShareHK$0.03
Dividend Yield6.98%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change66.67%
50-Day Moving Average0.43
200-Day Moving Average0.37
Relative Strength Index (RSI)46.49
Average Volume (3m)632.59K
Important Dates
Wai Yuen Tong Medicine Holdings Limited upcoming earnings date is Jun 30, 2026, TBA (Confirmed).
Last Earnings DateNov 24, 2025
Next Earnings DateJun 30, 2026
Ex-Dividend Date―
Financial Position
Wai Yuen Tong Medicine Holdings Limited as a current ratio of 1.73, with Debt / Equity ratio of 36.87%
Current Ratio1.73
Quick Ratio1.07
Debt to Market Cap0.85
Net Debt to EBITDA2.47
Interest Coverage Ratio-1.13
Taxes
In the past 12 months, Wai Yuen Tong Medicine Holdings Limited has paid -3.02M in taxes.
Income Tax-3.02M
Effective Tax Rate-0.74
Enterprise Valuation
Wai Yuen Tong Medicine Holdings Limited EV to EBITDA ratio is 5.77, with an EV/FCF ratio of 9.43.
EV to Sales0.95
EV to EBITDA5.77
EV to Free Cash Flow9.43
EV to Operating Cash Flow6.92
Balance Sheet
Wai Yuen Tong Medicine Holdings Limited has HK$146.55M in cash and marketable securities with HK$435.41M in debt, giving a net cash position of -HK$288.85M billion.
Cash & Marketable SecuritiesHK$146.55M
Total DebtHK$435.41M
Net Cash-HK$288.85M
Net Cash Per Share-HK$0.26
Tangible Book Value Per ShareHK$1.05
Margins
Gross margin is 50.51%, with operating margin of -4.25%, and net profit margin of 0.95%.
Gross Margin50.51%
Operating Margin-4.25%
Pretax Margin0.55%
Net Profit Margin0.95%
EBITDA Margin16.47%
EBIT Margin4.32%
Analyst Forecast
The average price target for Wai Yuen Tong Medicine Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast59.60%
EPS Growth Forecast-351.02%